KOCAA
COGT icon

Knights of Columbus Asset Advisors’s Cogent Biosciences COGT Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.94M Buy
50,156
+11,117
+28% +$389K 0.1% 219
2026
Q1 		$1.5M Buy
+39,039
New +$1.44M 0.08% 229

Other funds holding COGT

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.97B AUM 30.33% 1-Year Est. Return

Knights of Columbus Asset Advisors's COGT Position: Q2 2026 in Review

Knights of Columbus Asset Advisors increased its Cogent Biosciences (COGT) stake by 28% in Q2 2026, buying an estimated $389K and bringing the position to 50,156 shares worth $1.94M. The position accounts for 0.1% of the portfolio, ranked #219.

Knights of Columbus Asset Advisors first reported a position in COGT in Q1 2026 and has held it in 2 quarters since. 77 funds tracked by Wall St. Rank hold COGT as of Q2 2026.

  • Knights of Columbus Asset Advisors held 50,156 shares of Cogent Biosciences worth $1.94M as of Q2 2026.
  • Knights of Columbus Asset Advisors bought 11,117 Cogent Biosciences shares in Q2 2026, an estimated $389K.
  • Cogent Biosciences made up 0.1% of Knights of Columbus Asset Advisors's portfolio in Q2 2026, its #219 holding.
  • Knights of Columbus Asset Advisors first reported a position in Cogent Biosciences in Q1 2026 and has held it in 2 quarters since.
  • 77 funds tracked by Wall St. Rank held Cogent Biosciences as of Q2 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.